Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy

Stefano De Cillà, Serena Farruggio, Stela Vujosevic et al. · Cellular Physiology and Biochemistry · 2017 · 5.1K citations · Full text

A sharper Bonferroni procedure for multiple tests of significance

Yosef Hochberg · Biometrika · 1988 · 4.7K citations

Israel Search, December 1988, Multiple Tests +14

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

BMJ · 1994 · 3.1K citations

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text

Ocular Disease, Ophthalmology, Age-related Diseases +3